Effects of Immersive Virtual Reality on Balance of Parkinson's Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study, titled: Effectiveness of immersive virtual reality on balance in people with Parkinson's disease. Is a randomized clinical trial conducted at Zaragoza Parkinson's Association in Spain. It aims to evaluate the effectiveness of a immersive virtual reality program in enhancing balance for patients with Parkinson.s disease (PD). PD is a neurodegenerative disease that has a major impact on patients' balance and gait, affecting their quality of life. Physical rehabilitation is crucial for maintaining and improving balance, and immersive virtual reality promises to be an alternative for improving outcomes in patients with PD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 55
Maximum Age: 90
Healthy Volunteers: f
View:

• Diagnosis of PD confirmed by a neurologist

• Age between 55 and 90 years

• Hoehn \& Yahr Scale score of 1 to 4

• Cognitive level of 24 or higher on the Mini Mental Examination Test

• Ability to stand upright without assistance

Locations
Other Locations
Spain
Asociación de Parkinson de Aragón
RECRUITING
Zaragoza
Contact Information
Primary
Lorena Morcillo, Phd Student
lmorcillo@usj.es
+34 647 990 253
Backup
Sandra Calvo, PhD
sandracalvo@unizar.es
• +34 661 833 194
Time Frame
Start Date: 2025-02-05
Estimated Completion Date: 2026-05
Participants
Target number of participants: 50
Treatments
Experimental: Intervention Group. Immersive Virtual Reality Rehabilitation Program
The participants in the experimental group will receive a immersive virtual reality rehabilitation program to improve static and dynamic balance and quality of life.
Active_comparator: Control Group. Standard Rehabilitation Program
The participants in the control group will receive a standard physical therapy rehabilitation program to improve static and dynamic balance and quality of life
Related Therapeutic Areas
Sponsors
Leads: Instituto de Investigación Sanitaria Aragón
Collaborators: Universidad de Zaragoza, Universidad San Jorge

This content was sourced from clinicaltrials.gov